Fig. 2.
Comparison of overall survival time in systemic nodal ALCL.
Comparison is according to the percentage of active caspase 3–positive tumor cells (A), the percentage of Bcl-2–positive tumor cells (B), and expression of PI9 by tumor cells (C).
Comparison of overall survival time in systemic nodal ALCL.
Comparison is according to the percentage of active caspase 3–positive tumor cells (A), the percentage of Bcl-2–positive tumor cells (B), and expression of PI9 by tumor cells (C).
